GW-501516
Sign in to saveAlso known as Cardarine, GSK-516, GW 501516, GW1516, Endurobol, GW-516, GW 1516, GW-1516
GW501516 (also known as GW-501,516, GW1516, GSK-516, cardarine, and on the black market as endurobol) is a PPARδ receptor agonist that was invented in a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s. It entered into clinical development as a drug candidate for metabolic and cardiovascular diseases, but was abandoned in 2007 because animal testing showed that the drug caused cancer to develop rapidly in several organs.
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 453.06802
Show 3 more facts
- chemical formula
- C₂₁H₁₈F₃NO₃S₂
- canonical SMILES
- CC1=C(C=CC(=C1)SCC2=C(N=C(S2)C3=CC=C(C=C3)C(F)(F)F)C)OCC(=O)O
- Commons category
- GW501516
Sources (2)
via Wikidata · CC0
~8 min read
Encyclopedic overview
5 sectionsContents
- History
- Performance-enhancing drug
- Mechanism of action
- See also
- References
{{Drugbox | Verifiedfields = changed | verifiedrevid = 458657924 | IUPAC_name = {2-methyl-4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy}acetic acid | image = GW501,516.svg | image_class = skin-invert-image | width = 270
| tradename = | legal_AU = Scheduled as illegal from June 2018 | legal_US = unscheduled | legal_UK = unscheduled | routes_of_administration = By mouth | pregnancy_category = N/A
Excerpted from Wikipedia’s “GW-501516” article, available under the CC BY-SA 4.0 licence.
Available in 9 languages
via Wikidata sitelinks · CC0